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An intact helical domain is required for
Gα14 to stimulate phospholipase Cβ
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Abstract
Background: Stimulation of phospholipase Cβ (PLCβ) by the activated α-subunit of Gq (Gαq) constitutes a major
signaling pathway for cellular regulation, and structural studies have recently revealed the molecular interactions
between PLCβ and Gαq. Yet, most of the PLCβ-interacting residues identified on Gαq are not unique to members of
the Gαq family. Molecular modeling predicts that the core PLCβ-interacting residues located on the switch regions
of Gαq are similarly positioned in Gαz which does not stimulate PLCβ. Using wild-type and constitutively active
chimeras constructed between Gαz and Gα14, a member of the Gαq family, we examined if the PLCβ-interacting
residues identified in Gαq are indeed essential.
Results: Four chimeras with the core PLCβ-interacting residues composed of Gαz sequences were capable of binding
PLCβ2 and stimulating the formation of inositol trisphosphate. Surprisingly, all chimeras with a Gαz N-terminal half
failed to functionally associate with PLCβ2, despite the fact that many of them contained the core PLCβ-interacting
residues from Gα14. Further analyses revealed that the non-PLCβ2 interacting chimeras were capable of interacting
with other effector molecules such as adenylyl cyclase and tetratricopeptide repeat 1, indicating that they could
adopt a GTP-bound active conformation.
Conclusion: Collectively, our study suggests that the previously identified PLCβ-interacting residues are insufficient
to ensure productive interaction of Gα14 with PLCβ, while an intact N-terminal half of Gα14 is apparently required for
PLCβ interaction.
Background
The superfamily of G protein-coupled receptors (GPCRs)
constitutes the largest group of cell surface detectors for
extracellular signals. Upon ligand binding, conformational
changes in the receptor trigger the activation of heterotri-
meric G proteins, which consists of α, β, and γ subunits,
and results in the activation of various downstream effec-
tors [1, 2]. Gα proteins are classified into four main fam-
ilies named as Gαs, Gαi, Gαq, Gα12/13, while five Gβ and
twelve Gγ isoforms have been identified to date. The diver-
sity in G protein subunits allows disparate signaling path-
ways to be regulated by different receptors. Robust
stimulation of phospholipase Cβ (PLCβ) is primarily medi-
ated by GPCRs that utilize Gαq proteins for signaling [3],
thereby leading to diverse cellular responses that range
from cell proliferation to differentiation. The four known
isoforms of PLCβ (PLCβ1-4) [4] are all stimulated by
GTP-bound Gαq subunits [5], even though they are either
enriched in the cytosol (PLCβ2 and PLCβ3) or at the
plasma membrane (PLCβ1 and PLCβ4) [6]. PLCβ catalyzes
the hydrolysis of phosphatidylinositol 4,5-bisphosphate
(PIP2) into diacylglycerol and inositol 1,4,5-trisphosphate
(IP3), and reciprocally acts as a GTPase activating protein
(GAP) of Gαq [7, 8]. Since there are several members
within the Gαq subfamily (Gαq, Gα11, Gα14, and Gα15/
Gα16) and all are fully capable of stimulating PLCβ [5],
numerous GPCRs employ the Gαq/PLCβ pathway to
regulate different cellular functions. Moreover, the Gβγ
complex released upon G protein activation can also
stimulate PLCβ2 and PLCβ3 isoforms [9, 10]. Given the
importance of the Gαq/PLCβ axis in cell growth [11], its
dysregulation is expected to contribute to the pathophysi-
ology of various diseases. Indeed, somatic mutations caus-
ing constitutive activation of Gαq drive ~50 % of all uveal
melanomas [12].
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Despite intense efforts directed at understanding the
interactions of Gαq and PLCβ, the structure of a PLCβ-
Gαq complex has only been recently solved by molecular
replacement manipulations using the crystal structures
of PLCβ3 and an activated Gαq [13]. The predicted
structure of the PLCβ3-Gαq complex has identified a
series of discrete residues that form the interacting sur-
faces (Fig. 1a). According to the structural data, PLCβ3
binding occurs mainly at the switch regions of Gαq
(Fig. 1a and b). The switch I and II residues of Gαq
(green) interact with PLCβ3 through an extended loop
region between EF hands 3/4, which is conserved in all
PLCβ isoforms (Additional file 1: Figure S1), and the
region between the catalytic TIM barrel and C2 domain
of PLCβ3, providing an interface between PLCβ3 and
Gαq for interaction between a series of charged residue
pairs. The highly conserved helix-turn-helix segment
(Hα1/Hα2) at the C-terminus of the C2 domain of
PLCβ3 resides on the surface region formed by switch II
(α2-β4) and the α3 helix of Gαq and allows the formation
of various contacts with Gαq in the large binding interface
(Fig. 1c). More recently, discovery of the full-length struc-
tures of both PLCβ3 and Gαq in complex has highlighted
additional domains of PLCβ3 and Gαq necessary for acti-
vation of lipid hydrolysis and protein interactions [14].
The crystallized full-length PLCβ3 contains a distal
C-terminal domain (CTD) which is considered to be
important for activation, membrane localization, and
regulation by Gαq proteins [15, 16]. The distal CTD
adopts an orientation that makes direct contacts with the
αN helix of Gαq and most likely participates in binding
with Gα proteins.
Regions of the Gαq necessary for PLCβ interaction
(namely, Ile217 to Lys276 which encompass the α2-β4-α3-
β5 regions) have previously been identified by alanine-
scanning mutagenesis [17] and they are appropriately
positioned for the interaction with PLCβ3 (Fig. 1a). A
total of 33 amino acids in small clusters along the β2 to
α4 regions (except Ile21, Ile25, and Leu29, which lies in
the αN helix, and Lys41 which lies on the β1 strand) of
Gαq are predicted to form intermolecular bonds with
PLCβ [13, 14]. As expected, most interacting residues in
the core regions are conserved in all other Gαq members
including Gα11, Gα14, and Gα16 (Fig. 1a). However,
between 36 and 60 % of the identified PLCβ-interacting
residues are also found in other Gα protein families,
with members of the Gαi family having the highest hom-
ology to Gαq (Additional file 1: Figure S2) [18, 19]. For
instance, Gαz of the Gαi subfamily exhibits close to 60 %
identity with Gαq in the core PLCβ-interacting regions
(Fig. 1a). Such a high degree of identity is rather surprising
especially when Gα16, which stimulates PLCβ, is only 74 %
identical to Gαq in the PLCβ-interacting regions (Fig. 1a).
More interestingly, molecular modeling between Gαq and
Gαz predicts that their differences in the PLCβ-interacting
regions form a ring around a central core domain (Fig. 1b,
space filled models), with most of the PLCβ contact points
conserved between the two Gα subunits (Fig. 1c). This
calls into question whether the residues identified by
molecular replacement [13] are sufficient to provide
PLCβ binding selectivity to Gαq members. Although
the identified residues are involved in the formation
of the PLCβ3-Gαq complex and are necessary in PLCβ3
activation as confirmed in IP3 studies [13], there may be
additional regions in Gαq members that determine select-
ivity for PLCβ.
It has been well established that constitutively active
Gαq subunits can efficiently stimulate PLCβ [20] but has
no regulatory effect on adenylyl cyclase [21]. Early stud-
ies have employed chimeric Gαq/Gαs and Gα16/Gαz con-
structs to map the PLCβ and receptor interacting
domains on the Gαq and Gα16 subunits [17, 22]. It has
not been demonstrated whether other Gαq members
such as Gα14 (with over 80 % sequence similarity with
Gαq) utilize the same regions to interact with PLCβ.
Likewise, it remains to be determined if other PLCβ
isoforms such as PLCβ2 (with the highest resemblance to
PLCβ3; Additional file 1: Figure S1) employ similar struc-
tural regions as PLCβ3 for coupling to active Gαq. By gen-
erating a series of Gα subunit chimeras and testing their
abilities to functionally associate with PLCβ2 in HEK293
cells, we have demonstrated that an intact helical domain
in the N-terminus of Gα14 is necessary for productive
interaction with PLCβ.
Results
The PLCβ-interacting core regions of Gα14 are insufficient
to stimulate PLCβ2
The PLCβ-interacting surfaces of Gαq have been gener-
ally mapped to the β2-β3-α2-β4-α3 regions [13, 17], and
these residues are mostly conserved among Gα11, Gα14,
and Gα16 (Fig. 1a). Given that most of the PLCβ contact
sites of Gαq appear to be similarly present in Gαi subunits
(Additional file 1: Figure S2), it is possible to confer PLCβ-
stimulating function upon a Gαi subunit by incorporating
Gαq-specific residues. This will also allow for the identifi-
cation of any additional structural determinant on Gαq
which may specify interaction with PLCβ. In order to
distinguish exogenous from endogenous Gα subunits, we
have opted to use Gα14 as the backbone for constructing
chimeras instead of Gαq or Gα11. Unlike Gαq/11, Gα14 is
not expressed in HEK293 cells [23] and it differs from
Gαq by only two amino acids (Lys
256 and Thr296 in Gα14)
in the PLCβ-interacting regions (Fig. 1a, b). To determine
if Gα14 utilizes the same regions as Gαq for PLCβ
interaction, Gα14/Gαz chimeras were made by swapping
specific domains between Gα14 and Gαz. Gαz was selected
because it does not interact with PLCβ [24] or other Gαq
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Fig. 1 Alignment of PLCβ-interacting residues in Gαq family and Gαz. a Schematic view of Gαq divided into helical (light blue) and GTPase (light green)
domains with α-helices and β-strands represented by rectangles and ovals, respectively. Interacting domains of Gαq with PLCβ are indicated by yellow
boxes below the Gαq sequence; the three bold segments indicate the relative positions of the three switch regions (Sw1 to Sw3 from left to right).
Sequence alignment of PLCβ-interacting domains in the Gαq family as compared to that of Gαz; conserved (green) or divergent (red) PLCβ-interacting
residues are interspersed by conserved residues which are not implicated in interaction with PLCβ (grey). Residues forming direct interactions with
PLCβ3 as identified by Waldo et al. [13] are indicated by an asterisk. b Structural representation of Gαq, Gα14, and Gαz alignments with switch regions
(Sw1-3) and the α3 region. PLCβ3-interacting residues revealed in the sequence alignment are colored as indicated in A. Space filling models are
showing interacting surfaces. Structural models of Gα14 and Gαz are generated based on Gαq-PLCβ3 (PDB code: 3OHM) using SWISS-MODEL [65, 66].
Structure alignments are carried out with PyMOL (The PyMOL Molecular Graphics System, Version 1.3 Schrödinger, LLC). c Complex of Gαq/Gαz-PLCβ3.
The Gαq/Gαz aligned model is represented as indicated in (B). PLCβ3 (yellow) is depicted as a cartoon ribbon, containing the helix-turn-helix segment
(Hα1/Hα2), the N-terminal PH domain, four EF hands, the catalytic TIM barrel, and a C2 domain. The switch regions of Gαq interact with PLCβ3 through
an extended loop region between EF hands 3/4 and the region between the catalytic TIM barrel and C2 domain. The helix-turn-helix segment
(Hα1/Hα2) at the C-terminus of PLCβ3 resides on the surface region formed by switch 2 and α3 of Gαq. The αN helix of Gα proteins and
carboxy-terminal (CT) domain of PLCβ3 are not included in the structural models
Kwan et al. BMC Structural Biology  (2015) 15:18 Page 3 of 15
effectors such as TPR1 [25]. The chimeric approach is well
suited for mapping functional domains on the Gα sub-
units because their tertiary structures highly resemble one
another. Moreover, chimeras made with Gαz and Gα16
proteins are structurally viable [22, 25].
Molecular modeling predicts that the differences
between Gα14 and Gαz in the PLCβ-interacting regions
are distributed at the perimeters of the interacting
surfaces, in much the same way as those of Gαq versus
Gαz (Fig. 1b). Since most of the Gαz-specific sequences
in the PLCβ-interacting domain reside in the α2-β4-α3
regions (Fig. 1a), we began by testing the importance of
these regions by swapping the C-terminal half of Gαz
with Gα14 and assaying for the ability of the chimeras
to interact with PLCβ2; PLCβ2 was chosen on the basis
that it shares 76 % identity with PLCβ3 at the Gαq-
interacting residues [13, 14]. The 14z151 chimera was
constructed with the α2-β4-α3 regions together with
the rest of the C-terminus of Gα14 (151 residues)
replaced by the cognate sequence from Gαz; the mirror
image of 14z151 was also constructed and named as
203z14 (Fig. 2a). Construction of the chimeras was
guided by the predicted tertiary structure of the Gα
subunits as well as by our previous experience in deter-
mining the receptor and effector interacting domains of
various Gα subunits [22, 26–28]. A glutamine to
leucine point mutation (QL) was introduced at Gln205
(equivalent to Gln209 in Gαq) to generate constitutively
active mutants [29]. HEK293 cells were co-transfected
with PLCβ2 in combination with pcDNA1, wild-type or
constitutively active mutant of Gα14, Gαz, 14z151 or
203z14. As illustrated in Fig. 2b (upper panels), wild-
type and constitutively active Gα14, but not those of
Gαz, were successfully co-immunoprecipitated by anti-
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Fig. 2 The putative PLCβ domain of Gα14 is not required for PLCβ interaction and activation. a Schematic representation of the 14z151, 203z14,
14z173, and 182z14 chimeras. Predicted secondary structures are illustrated as boxes (α helices) or circles (β strands) above the chimeras. Black areas
represent human Gα14 sequence while those in grey signify the corresponding sequence of human Gαz. b HEK293 cells were co-transfected with
PLCβ2 and the indicated Gα protein or chimeras. Cell lysates from the transfectants were immunoprecipitated by anti-PLCβ2 antiserum. The
immunoprecipitates were immunoblotted with anti-Gα14, anti-Gαz or anti-PLCβ2 antiserum. Aliquots of cell lysates were used to detect the
expression levels of Gα14, Gαz and PLCβ by Western blot analysis (TCL). Data shown represent one of three sets of immunoblots; two other
sets yielded similar results. c HEK293 cells were transiently transfected with wild-type or constitutively active mutants (QL) of Gα protein or
chimeras. Cells were then labelled and assayed for IP3 formation. Fold stimulations were calculated as the ratios of QL-induced to wild-type
IP3 accumulations. Data represent the mean ± S.E.M. of three independent experiments, n = 3. *, IP3 production was significantly enhanced as
compared to corresponding wild-type transfected cells; Dunnett t test, p < 0.05
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PLCβ2 antiserum and protein G sepharose. Chimera
203z14 did not interact with PLCβ2 despite having the
α2-β4-α3 regions of Gα14 (Fig. 2b). This indicates that
the other PLC-interacting regions of Gα14 (e.g., β2 and
β3 regions) might be required for PLCβ2 interaction.
More surprisingly, 14z151 was pulled down by anti-PLCβ2
even though its α2-β4-α3 regions were composed of Gαz
sequences.
To test the possibility that the β2-β3 regions are needed
to maintain the overall structural integrity of the PLCβ-
interacting surfaces, we further constructed a pair of chi-
meras with the junction extended forward to include the
β2-β3 regions (Fig. 2a). Again, both the wild-type and con-
stitutively active mutant of the chimera which harbored the
β2-β3-α2-β4-α3 regions of Gα14 (182z14 and 182z14QL)
failed to associate with PLCβ2, while their mirror images
(14z173 and 14z173QL) co-immunoprecipitated with
PLCβ2 (Fig. 2b). All of the chimeras and PLCβ2 were
expressed at detectable and comparable levels in the total
cell lysates (Fig. 2b, lower panels). These results suggest that
the β2-β3-α2-β4-α3 regions, which are known to be im-
portant in Gαq for PLCβ interaction, might not be sufficient
for Gα14 to interact with PLCβ.
The co-immunoprecipitation results were subsequently
confirmed by PLCβ functional assays. HEK293 cells were
transfected with pcDNA1, Gα14, Gαz, the various chimeras
or their constitutively active mutants and then subjected to
IP3 accumulation assay. In agreement with previous
reports [24, 30], expression of Gα14QL but not GαzQL
significantly stimulated IP3 formation (Fig. 2c). Both
14z151QL and 14z173QL also stimulated IP3 production
whereas 182z14QL and 203z14QL failed to do so (Fig. 2c).
None of the wild-type chimeras significantly affected IP3
production as compared to the vector controls (results not
shown). Hence, these results demonstrate that the mere
presence of the β2-β3-α2-β4-α3 regions of Gα14 does not
necessarily confer upon the Gα subunit an ability to stimu-
late PLCβ. More interestingly, these regions can be func-
tionally replaced by those from Gαz.
To test if the replacement of the PLC-interacting
regions of Gα14 by cognate sequences from Gαz can in-
deed support PLCβ activation, we swapped the β2-β3 or
the α2-β4-α3 regions independently between the two Gα
subunits (Fig. 3a). Among the various PLC-interacting
regions, the α2 and α3 helices harbor most of residues
that have been identified to form intermolecular bonds
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Fig. 3 Role of β2-β3 and α2-β4-α3 regions of Gα14 in interaction and activation of PLCβ. a Schematic representation of zα2β4α3, 14α2β4α3,
zβ2β3 and 14β2β3 chimeras. b, Cells were co-transfected with PLCβ2 and Gα protein or the indicated chimeras. Co-immunoprecipitation assays
were performed and analyzed as in Fig. 2. Data shown represent one of three sets of immunoblots; two other sets yielded similar results. c HEK293 cells
were transiently transfected with the wild-type or constitutively active mutants (QL) of Gα proteins or chimeras and then subjected to IP3 accumulation
assay and analyzed as in Fig. 2. *, IP3 production was significantly enhanced as compared to corresponding wild-type transfected cells;
Dunnett t test, p < 0.05
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with PLCβ3 (Fig. 1a; [13]). Hence, substitution of the
α2-β4-α3 regions in Gα14 with those of Gαz might se-
verely disrupt the ability of the resultant chimera (named
as zα2β4α3) to interact with PLCβ. Although zα2β4α3
was co-immunoprecipitated by anti-PLCβ2 (Fig. 3b), its
constitutively active mutant displayed a much weaker
ability to induce IP3 formation as compared to Gα14QL
(Fig. 3c). In contrast, chimera 14α2β4α3 (the mirror image
of zα2β4α3) failed to associate or stimulate PLCβ2, sug-
gesting that the α2-β4-α3 of Gα14 alone was insufficient to
ensure PLCβ interaction. Likewise, we examined the role
of the β2-β3 strands of Gα14 in PLCβ interaction. Chimera
of Gα14 with the β2-β3 domain replaced by Gαz (zβ2β3),
and its mirror image (14β2β3), were constructed to deter-
mine if β2-β3 alone would affect PLCβ interaction with
Gα14 (Fig. 3a). Our results showed that zβ2β3 remained
capable of interacting with PLCβ and stimulating its activ-
ity (Fig. 3b, c), suggesting that the Gαz-specific residues in
this region are sufficiently similar to those of Gα14 to allow
productive interaction with PLCβ. On the other hand,
14β2β3 with most of the C-terminal and N-terminal of
Gα14 replaced by Gαz, failed to interact with PLCβ2 or
mediate IP3 production (Fig. 3b, c).
The N-terminal helical domain of Gα14 is important for
PLCβ interaction and activation
The preceding results suggested that the N-terminal half
(αN-αF) of Gα14 is seemingly important for PLCβ inter-
action and activation. Substituting the N-terminal of Gα14
from αN to αF with Gαz completely abolished the ability of
Gα14 to activate PLCβ even though the chimeras (182z14
and 203z14) can be successfully expressed (Fig. 2). To
narrow down the residues in αN-αF which are involved in
PLCβ activation, the N-terminal helical domain (αA-αF) of
Gα14 was split into two halves and replaced by cognate
sequences from Gαz (Fig. 4a). The helical domain is essen-
tial for maintaining the overall structure of the Gα subunit
and participates in effector regulation [31]. In order to
minimize possible disruption to the Gα structure, the chi-
meras were designed to switch from Gα14 to Gαz or vice
versa at a position in the middle of the helical domain
(Fig. 4a) where the residues of the two templates have high
homology. Chimera 14z224 harboring the αN-αC of Gα14
was expressed efficiently but was unable to functionally as-
sociate with PLCβ (Fig. 4b, c). The mirror image of
14z224, chimera 131z14, also failed to interact with PLCβ
or stimulate IP3 formation (Fig. 4b, c). Replacement of the
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Fig. 4 An intact N-terminal and helical domain are required for Gα14 mediated PLCβ interaction and activation. a Schematic representation of the
14z224, 131z14, 14αDEF and zαDEF chimeras. b, Cells were co-transfected with PLCβ2 and the indicated chimeras. Co-immunoprecipitation assays
were performed and analyzed as in Fig. 2. Data shown represent one of three sets of immunoblots; two other sets yielded similar results. c HEK293 cells
were transiently transfected with the wild-type or constitutively active mutants (QL) of Gα protein or the indicated chimeras and then subjected to IP3
accumulation assay and analyzed as in Fig. 2. *, IP3 production was significantly enhanced as compared to corresponding wild-type transfected cells;
Dunnett t test, p < 0.05
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second half of the helical domain (αD-αF) of Gα14 by Gαz
sequences, or vice versa, produced chimeras zαDEF and
14αDEF that neither interacted with PLCβ nor stimulated
IP3 formation (Fig. 4b, c). It should be noted that chimeras
131z14 and zαDEF contained the putative PLCβ-interacting
core domain (Fig. 4a).
The extreme N-terminus of the Gα subunit contains
motifs for membrane localization and is thus often re-
moved prior to crystallization [13]. By superimposing the
N-terminal αN helix onto the crystal structure of Gαq,
molecular modeling of the Gαq/PLCβ3 complex predicts
that the αN helix may represent a contact site for PLCβ3
(Fig. 5a). Given that several chimeras (14z151, 14z173,
zα2β4α3 and zβ2β3) were able to stimulate PLCβ activity
despite having the PLCβ-interacting core region from
Gαz, the provision of a Gα14 αN helix on a Gαz backbone
(14αN) might allow the resulting chimera to interact with
PLCβ. However, chimera 14αNQL (Fig. 5b) did not stimu-
late IP3 formation whereas chimera zαNQL (Gα14 back-
bone with a GαzαN helix) functionally interacted with
PLCβ (Fig. 5c). Collectively, these results suggest that the
αN helix is not a critical determinant in the recognition of
PLCβ by Gα14.
Non-PLCβ-interacting Gα14 chimeras can interact with
other effectors
Since nine chimeras (181z14, 203z14, 14α2β4α3, 14β2β3,
14z224, 131z14, zαDEF, 14αDEF, and 14αN) failed to
interact with PLCβ despite clear evidence of expression,
we sought to determine if these chimeric Gα subunits
were in fact functional. Those chimeras harboring large
segments of Gαz sequence may behave like Gαz and thus
be capable of inhibiting adenylyl cyclase. The panel of chi-
meras was therefore subjected to cAMP accumulation
assay. The ability of the constitutively active mutant of
each chimera to inhibit forskolin-induced cAMP accumu-
lation was compared to its corresponding wild-type
chimera (Fig. 6a). Like GαzQL, the constitutively active
mutants of 14β2β3, 14z224, 14αDEF, and 14αN inhibited
the forskolin response by 55-80 %, thereby confirming that
these chimeras can adopt an active conformation. With
four of the nine non-PLCβ-interacting chimeras demon-
strating an ability to inhibit adenylyl cyclase, only five
chimeras remained functionally unaccounted for.
Apart from being able to stimulate PLCβ by direct as-
sociation [32, 33], Gα14 can also activate the Ras/ERK
signaling pathway by interacting with TPR1 [34]. The
Gα/TPR1 interaction is important for IKK and STAT3
phosphorylation via the Ras/ERK pathway [35, 36] and is
apparently independent of PLCβ [25]. Since five chimeras
(203z14, 182z14, 131z14, zαDEF, and 14α2β4α3) failed to
exhibit any functional response in either IP3 or cAMP ac-
cumulation assays, we tested if these chimeras can associ-
ate with TPR1. HEK293 cells were co-transfected with an
N-terminal Flag-tagged TPR1 (Flag-TPR1) and either the
wild-type or the constitutively active mutant of Gα14,
Gαz, or a chimera. Transfectants were subjected to
co-immunoprecipitation using an anti-Flag affinity gel and
protein G sepharose. The immunoprecipitates and cell ly-
sates were then examined by western blot analysis using
anti-Flag and either anti-Gα14 or anti-Gαz antisera,
depending on whether the N-terminus of the chimera is
made up of Gα14 or Gαz sequences. In agreement with
previous studies [25, 34], neither Gαz nor GαzQL inter-
acted with Flag-TPR1 whereas both Gα14 and Gα14QL co-
immunoprecipitated with Flag-TPR1; noticeably more
Gα14QL was associated with Flag-TPR1 (Fig. 6b). In
contrast to Gαz, chimeras 203z14, 182z14, 131z14, and
14α2β4α3 were clearly detectable in the Flag-TPR1 immu-
noprecipitates (Fig. 6b); TPR1 interaction with 14α2β4α3
appeared to be weaker than the other chimeras. However,
zαDEF could not be co-immunoprecipitated by Flag-TPR1
(Fig. 6b). Hence, only zαDEF did not exhibit any response
in all of the functional assays. The ability of other chi-
meras to interact with Flag-TPR1 was similarly examined
(Additional file 1: Figure S3) and the results are summa-
rized in Table 1. Besides the inability of zαDEF to interact
with Flag-TPR1, 14β2β3 and 14αN also exhibited negli-
gible association with Flag-TPR1 but they were capable of
coupling to adenylyl cyclase (Fig. 6a).
Results obtained from the various assays are summa-
rized in Table 1. Collectively, these results suggest that
the core PLCβ-interacting regions are insufficient to
ensure productive interaction with PLCβ and, more
surprisingly, some of these regions can be functionally
substituted by cognate residues from Gαz. Interestingly,
an intact N-terminal helical domain (αA-αF) of Gα14 are
seemingly important for Gα14-mediated PLCβ activation.
Gα14 chimeras with αA-αF replaced entirely or in part
by Gαz can be expressed at a detectable level but failed
to interact with PLCβ2 or stimulate IP3 production.
Discussion
Structure and function correlations of members within
the same protein family are often based on extensive ana-
lyses of a prototypical member. In the case of the Gαq
family, it is generally assumed that all members interact
with the canonical effector PLCβ in much the same way
as Gαq. The biochemical functions of Gαq family members
are almost indistinguishable [33, 37] except for their abil-
ity to recognize specific receptors [38]. Hence, it is rather
surprising that the putative PLCβ-interacting domains
identified from studies on Gαq [13, 14, 17, 39] are simply
insufficient to support efficient regulation of PLCβ by
Gα14. Although detailed structural comparison between
Gαq and Gα14 is not feasible because of the lack of Gα14
structural data, the overall sequence similarity of over
80 % indicates a highly conserved three-dimensional
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structure shared by both proteins [18, 19]. Since the struc-
tural homology and the residues responsible for PLCβ
interaction and activation are presumably conserved from
Gαq to Gα14, one would expect that Gα14 may utilize the
same residues for PLCβ activation. It should also be noted
that sequence variations in interacting residues of PLCβ2
and PLCβ3 may affect the ability of Gα14 to efficiently
stimulate PLCβ2. In particular, conservative substitutions
such as D973E and Q1066S in the distal CTD may have
limited consequences for Gα14 binding, whereas more se-
vere mutations in other interacting regions (E261S, Y855L,
and R1062A) may significantly affect efficient activation by
Gα proteins. Nonetheless, the substantial amount of con-




Fig. 5 Role of the N-terminal helix (αN) in the Gαq-PLCβ3 complex. a The model of Gαq (light orange) is shown as a space filling structure and
contains the αN-helix and other regions as indicated. PLCβ3 (yellow) is depicted as a cartoon ribbon, containing the helix-turn-helix segment
(Hα1/Hα2), the N-terminal PH domain, four EF hands, the catalytic TIM barrel, and a C2 domain. PLCβ3-interacting residues of Gαq are colored
in magenta. The carboxy-terminal (CT) domain of PLCβ3 is not included in the structural model. The structure of the αN-helix is generated by
replacing the amino acid sequence of Gαi (Gαiβ1γ2, PDB code: 1GP2) with the Gαq sequence. The final model is generated by alignment of
Gαq-PLCβ3 (PDB code: 3OHM) and the modified heterotrimer Gαqβ1γ2 using PyMOL (The PyMOL Molecular Graphics System, Version 1.3
Schrödinger, LLC). The orientation of the αN-helix represents the conformation in the heterotrimer and is not optimized for the Gαq-PLCβ3
complex. In this case, the αN-helix points towards the cell membrane and clashes with PLCβ3, but in fact may exist in a conformation which
interacts with PLCβ3. b Schematic representation of 14αΝ and zαN chimeras. c Cells were co-transfected with PLCβ2 and Gα protein or the indicated
chimeras. Co-immunoprecipitation assays were performed and analyzed as in Fig. 2. Data shown represent one of three sets of immunoblots; two
other sets yielded similar results. For the IP3 accumulation assay, HEK293 cells were transiently transfected with the wild-type or constitutively active
mutants (QL) of Gα proteins or chimeras and analyzed as in Fig. 2. *, IP3 production was significantly enhanced as compared to corresponding
wild-type transfected cells; Dunnett t test, p < 0.05
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provide sufficient interacting regions for effector activation.
However, Gα14/Gαz chimeras lacking the putative PLCβ
interacting domain (e.g., 14z151 and 14z173) are fully
capable of interacting and stimulating PLCβ. Since these
gain-of-function results do not correspond with current
structural information on Gαq/PLCβ interaction [13, 14], it
would appear that our understanding on how G proteins
stimulate the PLCβ pathway is far from complete.
Gα14 and Gαq resemble each other both structurally and
biochemically. Both proteins are able to stimulate PLCβ2
and exhibit similar profiles of IP3 production [32]. Similar
to other members of the Gαq subfamily, Gα14 links a
variety of Gq-, Gs-, and Gi- coupled receptors to stimulate
PLCβ3 [40–42]. In addition, palmitoylation of cysteine
residues in the N termini of Gαq and Gα14 is essential for
membrane localization and efficient PLCβ activation
[43, 44]. However, co-immunoprecipitation and PLCβ acti-
vation studies using Gα14/Gαz chimeras suggested that an
intact helical domain (αN-αF) of Gα14, but not the previ-
ously identified PLCβ3 interacting regions (α2-β4-α3-β5),
is required for PLCβ interaction and activation. It should
be noted that each Gα protein can be divided into the
GTPase domain that comprises the PLCβ interacting
regions and the helical domains composed of αA to αF
A
B
Fig. 6 Ability of different chimeras to interact with AC and TPR1. a HEK293 cells were transiently transfected with the wild-type or constitutively active
mutants of Gα protein and chimeras indicated in the figure. The transfectants were labelled with [3H]adenine (1 μCi/ml) in 1 % FBS/MEM. The labelled
cells were treated with 50 μM of FSK for 30 min before subjected to cAMP accumulation assay. cAMP fold inhibition was calculated as the ratios of
QL-induced to wild-type cAMP inhibition. Data represent the mean ± S.E.M. of three independent experiments, n = 3. *, cAMP accumulation was
significantly inhibited as compared to corresponding wild-type transfected cells; Dunnett t test, p < 0.05. b HEK293 cells were transiently co-transfected
with FLAG-TPR1 in combination with Gα proteins and the indicated chimeras. Cell lysates were immunoprecipitated by anti-FLAG affinity agarose gel.
The immunoprecipitates were immunoblotted with anti-Gα14, anti-Gαz or anti-FLAG antiserum. Crude lysates were used to examine the expression
levels of Gα14, Gαz, Gα14/Gαz chimeras or FLAG-TPR1 by Western blot analysis. The immunoblots shown represent one of three sets of immunoblots;
two other sets yielded similar results
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helices [31]. There is increasing evidence to suggest that
the helical domain participates in the activation and regula-
tion of the Gα subunit [45]. For instance, the helical
domain of Gα16 is known to bind GRK2 [46]. Substitu-
tion of the previously identified PLCβ3 interacting
regions (α2-β4-α3-β5) of Gα14 by Gαz is expected to
abolish PLCβ interaction and activation. However,
Gα14/Gαz chimeras consisting of varying combinations
of the interacting regions were able to interact and acti-
vate PLCβ. Most surprisingly, the 14z151QL chimera,
consisting of an entire α2-β4-α3-β5 region of Gαz, was
able to stimulate IP3 production to similar levels as Gα14,
indicating that this region is not responsible for specifying
interaction with PLCβ. The reduction in PLCβ activity of
the 14z173QL chimera, consisting of an additional substi-
tution of the adjacent β2-β3 region by Gαz, could be
caused by its weaker binding with PLCβ, as lower protein
levels of the chimera were observed in complex with
PLCβ in the co-immunoprecipitation assay (Fig. 2b). Also,
a GTPase domain consisting of an intact α2-β4-α3-β5
region of either Gα14 or Gαz seems important for maximal
activation of PLCβ. The zα2β4α3QL chimera disrupts this
region and decreased IP3 production was observed with-
out obvious binding defects as determined in the co-
immunoprecipitation assay. In general, chimeras with sub-
stitutions in the GTPase domain of Gα14 showed limited
binding defects but significant effects on IP3 production,
which emphasizes the importance of the GTPase domain
in PLCβ activation as compared to its less prominent role
in protein binding.
Further co-immunoprecipitation and PLCβ activation
studies using Gα14/Gαz chimeras suggested that the
helical domain of Gα14 is required for PLCβ activation.
Replacing either half (amino acids 1–131, or 132–181) of
the N-terminus of Gα14 by Gαz disrupted the ability of the
chimeras (14z224, 131z14, zαDEF, and 14αDEF) to inter-
act with PLCβ, suggesting that an intact helical core is
necessary for PLCβ binding. To date, the sites for effector
binding have been mostly mapped to the GTPase domain
[13, 14, 17, 39, 47, 48], while much less is known about
the function of the helical domain. The helical domain is
the most divergent among Gα subunits [49]. Early struc-
tural and sequence analyses on Gα predicted that the
helical domain is involved in effector interaction and may
act as a regulatory entry point for GPCRs and Gβγ sub-
units [49, 50]. Together with the GTPase domain, it forms
the nucleotide binding pocket and regulates GDP/GTP
exchange by altering the binding affinity of Gα and its
substrate [51, 52]. It has been proposed to participate in G
protein oligomerization [53] and in the transition between
the inactive and active conformations of Gα [54]. Fur-
thermore, the helical domain of Gαs has been proposed to
accelerate GTP hydrolysis by the GTPase domain, func-
tioning as a GTPase-activating protein (GAP) [55]. A
study using human/Xenopus chimeras of Gαs subunit re-
vealed that the helical domain of Gαs is also important for
Table 1 Functional characterizations of the chimeras and their correlation with intact PLCβ or Gα14 helical domains
PLCβ stimulation Adenylyl cyclase inhibition PLCβ interaction TPR1 interaction Intact PLCβ domain Intact Gα14 helical domain
Gα14 Yes No Yes Yes Yes Yes
203z14 No No No Yes Yes No
14z151 Yes No Yes Yes No Yes
182z14 No No No Yes Yes No
14z173 Yes No Yes Yes No Yes
14β2β3 No Yes No No No No
zβ2β3 Yes No Yes Yes Yes Yes
14z224 No Yes No Yes No No
131z14 No No No Yes Yes No
14αDEF No Yes No Yes No No
zαDEF No No No No Yes No
14α2β4α3 No Yes No Yes No No
zα2β4α3 Yes No Yes Yes No Yes
14αN No Yes No No No No
zαN Yes No Yes Yes Yes Yes
Gαz No Yes No No No No
Results of Gα proteins and chimeras in functional studies and co-immunoprecipitation assays are summarized. PLCβ stimulation was determined by measuring IP3
production by constitutively active (QL) chimeras as compared to their corresponding wild type activity (Figs. 2c, 3c, 4c, and 5c). The ability of QL-chimeras to
inhibit adenylyl cyclase was determined in FSK-induced cAMP accumulation assays (Fig. 6a). Co-immunoprecipitation assays were performed using anti-PLCβ2 and
anti-FLAG for the detection of PLCβ (Figs. 2b, 3b, 4b, and 5c) and TPR1 (Fig. 6b), respectively. Constructs containing an intact PLCβ binding domain (α2-β4-α3-β5
region) or an intact helical domain (αA-αF region) of Gα14 are also shown
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the activation of adenylyl cyclase [56]. More recently,
crystallization studies suggest that major displacement of
the helical domain is required for receptor coupling [57],
thereby proposing a role for the helical domain as the
inhibitory barrier for receptor-dependent activation. Con-
sidering the potential functions of the helical domain, our
present study supports the involvement of the helical
domain in effector interaction and regulation.
According to recent structural data, the αN helix is an
important structure of Gα subunits in many aspects [14].
It is required for the binding of Gβγ [58, 59] and GPCRs
[27, 60, 61]. It is also the site of lipid modification which
enables proper localization of the G proteins to the plasma
membrane (reviewed in [62]). Truncation of the αN helix
of Gαq decreased Gαq-stimulated PLCβ3 activity without
affecting the binding affinity (Ki) with PLCβ3 [14]. Like-
wise, mutations in the hydrophobic surface of the distal
CTD of PLCβ3, which is thought to form interactions with
the αN helix of Gαq, did not decrease the binding affinity
while IP3 production was still observed at considerable
levels [14]. Consistently, our zαNQL chimera with the αN
helix of Gα14 replaced by Gαz did not show binding defects
in co-immunoprecipitation assays and successfully induced
IP3 production. Moreover, removal of the distal CTD do-
main of PLCβ3 has been shown to significantly inhibit IP3
production while only modestly affecting the binding affin-
ity with Gαq [14]. These results suggest that interaction
between the distal CTD of PLCβ3 and the αN helix of Gαq
or Gα14 is important for maximal stimulation of PLCβ3
and plays a less prominent role in Gα protein binding.
Gαz belongs to the Gαi subfamily and is able to inhibit
adenylyl cyclase (AC) activity and subsequent cAMP pro-
duction by direct association with AC (Fig. 6). Accord-
ingly, substitution of Gαz by portions of Gα14 structure
may affect the level of inhibition of cAMP production.
Disruption of the GTPase domain of Gαz, as demon-
strated by the 14α2β4α3 chimera, abolishes the ability of
Gαz to inhibit AC. The 14z224QL chimera significantly
inhibited cAMP production as compared to 14z173QL,
which lacks the αDEF region of Gαz and was unable to in-
hibit AC. However, the 14αDEFQL chimera with an αDEF
region of Gαq significantly inhibited AC at comparable
levels. Moreover, chimeras lacking the entire helical
domain of Gαz (14z151 and 14z173) were unable to in-
hibit AC. These results suggest that both an intact GTPase
domain of Gαz, which agrees with previously reported
literature [39, 48], and at least a portion of the helical
domain of Gαz is required for AC inhibition.
Gα14 and Gα16 belong to the same family and share
high homology in terms of their amino acid sequence
and signaling properties. Both Gα14 and Gα16 have been
shown to activate Ras and downstream transcription
factors such as NFκB and STAT3 through interaction
with TPR1 [25, 34]. Previous studies using Gα16/Gαz
chimeras suggested that the β2 and β3 strands of Gα16 are
important for the interaction with TPR1 but this is not
necessarily the case for Gα14. Co-immunoprecipitation
studies using Gα14/Gαz chimeras (summarized in Table 1)
suggest that TPR1 interacts with Gα14 and Gα16 through
different structural regions. As demonstrated by the
zαDEF chimera, the αDEF region of Gα14 seems necessary
for interaction with TPR1. However, several chimeras
lacking this region, including 182z14, 203z14, and
131z14, are able to interact with TPR1. The inability
of the zαDEF chimera to interact with TPR1 could be
caused by disruption of the helical domain resulting
in instability of the protein structure. Disruption of
the GTPase domain and substitution of the helical
domain by Gαz, as demonstrated by the zα2β4α3
chimera, did not completely abolish TPR1 interaction.
Moreover, the mirror image pairs 14z151 and 203z14,
as well as 14z173 and 182z14, were able to interact
with TPR1. These results indicate that the presence of
either the α2-β4-α3 region of the GTPase domain or
an intact helical domain of Gα14 is sufficient for
TPR1 interaction.
Conclusion
The present study has successfully used chimeric Gα14/
Gαz constructs to map critical regions for effector regu-
lation and demonstrates the insufficiency of previous
structural information in supporting efficient effector
regulation by Gα proteins. Although the roles of the αN
helix and helical domain of Gα subunits in G protein-
mediated signal transduction have mostly been neglected,
our results designate important roles for these domains of
Gα14 in effector interaction and activation.
Methods
Reagents
The human cDNAs of Gα14, Gα14QL were obtained from
Guthrie Research Institute (Sayre, PA, USA). Cell culture
reagents, including LipofectAMINE PLUS reagents, and
Lipofectamin 2000 were purchased from Invitrogen
(Carlsbad, CA, USA). Anti-Gα14 targeting the N-terminal
was obtained from Gramsch Laboratories (Schwabhausen,
Germany). Anti-FLAG antibody and anti-FLAG affinity
gel were from Sigma-Aldrich (St. Louis, MO, USA). Other
antibodies were purchased from Cell Signaling Technology
(Danvers, MA, USA). Protein G-agarose and dithiobis[suc-
cinimidylpropionate] (DSP) cross-linker were from Pierce
Biotechnology (IL, USA). Osmonics nitrocellulose mem-
brane and ECL kit were from Westborough (MA, USA)
and Amersham (Piscataway, NJ, USA), respectively.
Pertussis toxin (PTX) was obtained from List Biological
Laboratories (Campbell, CA, USA), and octreotide (OCT)
was from Sigma-Aldrich (St. Louis, MO, USA).
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Cell culture and co-immunoprecipitation
HEK293 cells were obtained from the American Type
Culture Collection (CRL-1573, Rockville, MD). They
were maintained in Eagle’s minimum essential medium
at 5 % CO2, 37 °C with 10 % fetal bovine serum, 50
units/mL penicillin and 50 μg/mL streptomycin. For co-
immunoprecipitation experiments, HEK293 cells were
grown to 80 % confluency in 100 mm tissue culture plates
and then co-transfected with 200 ng Gα and 200 ng
FLAG-TPR1 cDNAs using 15 μL PLUS and LipofectA-
MINE reagents in Opti-MEM. Serum was replenished 3 h
after transfection. Cross-linking was performed one day
after transfection; transfected HEK293 cells were washed
with PBS twice and then treated with 0.5 mM DSP in PBS
for 15 min at room temperature. Cells were then washed
again with PBS and maintained in quenching solution
(50 mM glycine in PBS, pH 7.4) for 5 min. Subsequently,
cells were lysed in ice-cold RIPA buffer (25 mM HEPES at
pH 7.4, 0.1 % SDS, 1 % Nonidet P-40, 0.5 % sodium deox-
ycholate, 1 mM dithiothreitol, 200 μM Na3VO4, 4 μg/mL
aprotinin,100 μM phenylmethylsulfonyl fluoride, and
2 μg/mL leupeptin). Cell lysates were gently rocked with
an anti-Gα14 antiserum at 4 °C overnight, and then incu-
bated in 30 μL protein G-agarose (50 % slurry) at 4 °C for
2 h. Alternatively, the cell lysates were incubated in 30 μL
anti-FLAG affinity agarose gel (50 % slurry) at 4 °C over-
night. Immunoprecipitates were washed with ice-cold
RIPA buffer (400 μL) for four times, resuspended in 50 μl
RIPA buffer and 10 μl 6× sample buffer and then boiled
for 5 min. Gα14 and FLAG-TPR1 proteins in the immuno-
precipitates were analyzed by Western blots.
Construction of chimeras
Gα chimeras were constructed from cDNAs encoding
human Gα14 and Gαz by using polymerase chain reaction
(PCR) techniques. The N-terminal 37, 131, 182 and 203
residues of Gα14 were substituted by the corresponding
amino acids of Gαz to generate zαN, 131z14, 182z14 and
203z14 chimeras, respectively. Primers were designed to
produce two half-length fragments with overlapping re-
gions; the forward fragment was generated with the anti-
sense and T7 primers, whereas the backward fragment
was made with the sense and reverse primers which target
a BGH polyadenylation signal (BGH primers). The two
half-products were then annealed together to generate a
full-length fragment by another round of PCR using T7
and BGH primers. Mirror images of these constructs were
generated analogously and were named 14αN, 14z224,
14z173 and 14z151 chimeras. PCR (30 cycles each with
94 °C for 60 s, 58 °C for 60 s and 72 °C for 90 s) was
carried out using AccuPrime PCR mix. The 14β2β3
chimera was constructed using 182z14 as the DNA
template for the forward half-product and 14z151 DNA
template for the backward half-product. The zβ2β3
chimera was constructed using 14z173 as the DNA
template for the forward half-product and 203z14 as the
DNA template for the backward half-product. 14α2β4α3
was constructed using 203z14 as the template for the
forward half product and Gαz as the template for the
backward half product. Its mirror image zα2β4α3 was
constructed using 14z151 as the template for the forward
half product and Gα14 for the backward half product.
Finally, 14αDEF was constructed using 131z14 as the
DNA template for the forward half-product and Gαz as
template for the backward half-product. Its mirror image
zαDEF was constructed using 14z224 as the DNA tem-
plate for the forward half-product and Gα14 as template
for the backward half-product. Primers for chimera
construction are listed in Table 2. All Gα chimeras were
checked by restriction mapping and then subcloned into
pcDNA3 at HindIII and XbaI sites. The constructs were
confirmed by dideoxynucleotide sequencing using Applied
Biosystem Big Dye Terminator v3.1 Cycle Sequencing Kits
(Foster City, CA, USA).
Inositol Phosphates (IP3) accumulation assay
HEK293 cells were seeded on a 12-well plate at 2 × 105
cells/well one day prior to transfection. Cells were then
transfected with 200 ng Gα using 2 μL PLUS and Lipo-
fectamine reagents in Opti-MEM. On the next day, cells
were labeled with inositol-free Dubecco’s modified
Eagle’s medium (DMEM; 750 μL) containing 5 % FBS
and 2.5 μCi/mL myo-[3H]inositol overnight. Labeled
cells were washed twice with the inositol phosphates
assay medium (DMEM buffered with 20 mM HEPES,
pH 7.5 and 5 mM LiCl) and were incubated for 1 h at
37 °C. Reactions were stopped by replacing the assay
medium with 750 μL ice-cold 20 mM formic acid and
the lysates were kept in 4 °C for 30 min before the
separation of [3H]IP from other labeled species by
sequential ion-exchange chromatography as described
previously [63].
cAMP accumulation assay
HEK293 cells were labeled overnight with [3H]adenine
(1 μCi/ml) in culture medium containing 1 % FBS. The
labeled cells were rinsed once with 2 ml of assay
medium (MEM containing 20 mM HEPES, pH 7.4) and
incubated at 37 °C for 30 min with 1 ml of assay
medium containing 1 mM 1-methyl-3-isobutylxanthine
in the absence or presence of 50 μM forskolin. The cells
were lysed with 1 ml 5 % trichloroacetic acid with 1 mM
ATP to terminate the reaction and were stored at 4 °C
for 1 h. Intracellular [3H]cAMP was isolated by sequen-
tial chromatography as described previously [64]. The
level of [3H]cAMP was estimated by determining the ra-
tios of [3H]cAMP to total [3H]ATP and [3H]ADP pools.
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Molecular modeling
Gαq in a complex with PLCβ3 (PDB ID: 3OHM, [13])
was employed to illustrate the interaction between Gα
and PLCβ, and for creating a molecular model of Gα14by
homologous modeling using SWISS-MODEL [65, 66].
Visualization of various structures was accomplished
using PyMOL (The PyMOL Molecular Graphics System,
Version 1.3 Schrödinger, LLC).
Western blotting analysis
Protein samples were resolved on 12 % SDS-polyacryla-
mide gels and transferred to Osmonics nitrocellulose
membrane. Resolved proteins were detected by their
specific primary antibodies and horseradish peroxidase-
conjugated secondary antisera. The immunoblots were
visualized by chemiluminescence with the ECL kit from
Amersham, and the images detected in X-ray films were
quantified by densitometric scanning using the Eagle
Eye II still video system (Stratagene, La Jolla, CA, USA).
Additional file
Additional file 1: Figure S1. Alignment of Gαq-interacting residues in
the PLCβ family. Figure S2. Alignment of PLCβ-interacting residues in
the Gα protein family. Figure S3. Interaction of Gα14/Gαz chimeras with
Flag-TPR1. (PPTX 306 kb)
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Table 2 Primer sequences for constructing various Gα14/z chimeras
Chimera Templates Primers
203z14 Gαz/Gα14 F: 5’- ATGGTGGACGTGGGGGGCCAACGATCGGAA -3’
R: 5’- TTCCGATCGTTGGCCCCCCACGTCCACCAT -3’
14z151 Gα14/Gαz F: 5’- ATGGTGGATGTTGGTGGGCAGAGGTCAGAG -3’
R: 5’- CTCTGACCTCTGCCCACCAACATCCACCAT -3’
182z14 Gαz/Gα14 F: 5’- CGCTCCCGGGACATGACCACCGGCATCATT -3’
R: 5’- ATTGATGCCGGTGGTCATGTCCCGGGAGCG -3’
14z173 Gα14/Gαz F: 5’- CGCGTCCGAGTGCCCACCACGGGCATTGTG -3’
R: 5’- CACAATGCCCGTGGTGGGCACTCGGACGCG -3’
14β2β3 182z14/14z151 F: 5’- ATGGTGGATGTTGGTGGGCAGAGGTCAGAG -3’
R: 5’- CTCTGACCTCTGCCCACCAACATCCACCAT -3’
zβ2β3 14z173/203z14 F: 5’- ATGGTGGACGTGGGGGGCCAACGATCGGAA -3’
R: 5’- TTCCGATCGTTGGCCCCCCACGTCCACCAT -3’
14z224 Gα14/Gαz F: 5’- GCCATCAAGCAGCTCTGGGCCGACCCAGGG -3’
R: 5’- CCCTGGGTCGGCCCAGAGCTGCTTGATGGC -3’
131z14 Gαz/Gα14 F: 5’- GTCATGCGACGGCTCTGGCAAGATCCAGGC -3’
R: 5’- GCCTGGATCTTGCCAGAGCCGTCGCATGAC -3’
14αDEF 131z14/Gαz F: 5’- CGCGTCCGAGTGCCCACCACGGGCATTGTG -3’
R: 5’- CACAATGCCCGTGGTGGGCACTCGGACGCG -3’
zαDEF 14z224/Gα14 F: 5’- CGCTCCCGGGACATGACCACCGGCATCATT -3’
R: 5’- AATGATGCCGGTGGTCATGTCCCGGGAGCG -3’
14α2β4α3 203z14/Gαz F: 5’- ATGGTGGACGTGGGGGGCCAACGATCGGAA -3’
R: 5’- TTCCGATCGTTGGCCCCCCACGTCCACCAT -3’
zα2β4α3 14z151/Gα14 F: 5’- ATGGTGGATGTTGGTGGGCAGAGGTCAGAG -3’ R: 5’- CTCTGACCTCTGCCCACCAACATCCACCAT -3’
14αN Gα14/Gαz F: 5’- GGGCAGAGGTCAGAGCGCGAAATCAAGCTG -3’ R: 5’- CAGCTTGATTTCGCGCTCTGACCTCTGCCC -3’
zαN Gαz/Gα14 F: 5’- AGCCAGCGGCAACGCCGTGAGCTTAAGCTG -3’ R: 5’- CAGCTTAAGCTCACGGCGTTGCCGCTGGCT -3’
Bold and italic nucleotides denote the Gα14-derived sequences. F, forward primer; R, reverse primer
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